Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, et al. Cancer statistics for the year 2020: an overview. Int J Cancer. 2021;149(4):778–89.
Miller KD, Ortiz AP, Pinheiro PS, Bandi P, Minihan A, Fuchs HE, Martinez Tyson D, Tortolero-Luna G, Fedewa SA, Jemal AM et al: Cancer statistics for the US Hispanic/Latino population, 2021. Cancer J Clin. 2021;71(6):466–87
Cao W, Chen HD, Yu YW, Li N, Chen WQ. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020. Chin Med J. 2021;134(7):783–91.
Article
PubMed
PubMed Central
Google Scholar
Hayat MJ, Howlader N, Reichman ME, Edwards BK. Cancer statistics, trends, and multiple primary cancer analyses from the surveillance, epidemiology, and end results (SEER) program. Oncologist. 2007;12(1):20–37.
Article
PubMed
Google Scholar
Wang Y, Li J, Chang S, Dong Y, Che G. Risk and influencing factors for subsequent primary lung Cancer after treatment of breast Cancer: a systematic review and two Meta-analyses based on four million cases. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2021;16(11):1893–908.
Article
CAS
Google Scholar
Jolliffe IT, Cadima J. Principal component analysis: a review and recent developments. Philosophical transactions Series A, Mathematical, physical, and engineering sciences. 2016;374(2065):20150202.
PubMed
PubMed Central
Google Scholar
Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27–30.
Micale L, Fusco C, Augello B, Napolitano LM, Dermitzakis ET, Meroni G, et al. Williams-Beuren syndrome TRIM50 encodes an E3 ubiquitin ligase. European journal of human genetics : EJHG. 2008;16(9):1038–49.
Article
CAS
PubMed
Google Scholar
Li S, Wang L, Zhao Q, Wang Z, Lu S, Kang Y, et al. Genome-wide analysis of cell-free DNA methylation profiling for the early diagnosis of pancreatic Cancer. Front Genet. 2020;11:596078.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hatakeyama S. TRIM proteins and cancer. Nat Rev Cancer. 2011;11(11):792–804.
Article
CAS
PubMed
Google Scholar
Hatakeyama S. TRIM family proteins: roles in autophagy, immunity, and carcinogenesis. Trends Biochem Sci. 2017;42(4):297–311.
Article
CAS
PubMed
Google Scholar
Wang S, Zhang Y, Huang J, Wong CC, Zhai J, Li C, et al. TRIM67 activates p53 to suppress colorectal Cancer initiation and progression. Cancer Res. 2019;79(16):4086–98.
CAS
PubMed
Google Scholar
Watanabe M, Hatakeyama S. TRIM proteins and diseases. J Biochem. 2017;161(2):135–44.
CAS
PubMed
Google Scholar
Wang M, Chao C, Luo G, Wang B, Zhan X, Di D, et al. Prognostic significance of TRIM59 for cancer patient survival: a systematic review and meta-analysis. Medicine (Baltimore). 2019;98(48):e18024.
Article
CAS
Google Scholar
Liang Q, Tang C, Tang M, Zhang Q, Gao Y, Ge Z. TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4. J Exp Clin Cancer Res. 2019;38(1):159.
Article
PubMed
PubMed Central
Google Scholar
Chen L, Xubin Z, Zheng C, Zhijun M: The molecular mechanism of E3 ubiquitin ligase TRIM50 promoting proliferation, migration and invasion of oral squamous cell carcinoma. J Shanxi Med Univ. 2021;52(02):141–151
Juanhua W, Jiaojiao G, Yunyang C, Jiexiong Y, Naile K, Haochuan H. Expression of TRIM47 and its significance in liver cancer base on bioinformatic test. Chin J Hepat Surg (Electronic Edition). 2021;10(01):98–103.
Google Scholar
Jingtao Z. TRIM35 promotes the proliferation, migration and invasion of lung cancer cells in vivo and in vitro. Nanchang University; 2020.
Liang J, Liu J, Deng Z, Liu Z, Liang L. DLX6 promotes cell proliferation and survival in oral squamous cell carcinoma. Oral Dis. 2020;28(1):87–96.
Kohtz JD, Fishell G. Developmental regulation of EVF-1, a novel non-coding RNA transcribed upstream of the mouse Dlx6 gene. Gene Expr Patterns. 2004;4(4):407–12.
Article
CAS
PubMed
Google Scholar
Lo Iacono N, Mantero S, Chiarelli A, Garcia E, Mills AA, Morasso MI, et al. Regulation of Dlx5 and Dlx6 gene expression by p63 is involved in EEC and SHFM congenital limb defects. Development. 2008;135(7):1377–88.
Article
CAS
PubMed
Google Scholar
Hull S, Attanasio M, Arno G, Carss K, Robson AG, Thompson DA, et al. Clinical characterization of CNGB1-related autosomal recessive retinitis Pigmentosa. JAMA Ophthalmol. 2017;135(2):137–44.
Article
PubMed
Google Scholar
Xiang Q, Guo Y, Cao Y, Xiong W, Deng X, Xu H, et al. Identification of a CNGB1 Frameshift mutation in a Han Chinese family with retinitis Pigmentosa. Optom Vis Sci. 2018;95(12):1155–61.
Article
PubMed
Google Scholar
Werner S, Smola H, Liao X, Longaker MT, Krieg T, Hofschneider PH, et al. The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. Science. 1994;266(5186):819–22.
Article
CAS
PubMed
Google Scholar
Volckaert T, Dill E, Campbell A, Tiozzo C, Majka S, Bellusci S, et al. Parabronchial smooth muscle constitutes an airway epithelial stem cell niche in the mouse lung after injury. J Clin Invest. 2011;121(11):4409–19.
Article
CAS
PubMed
PubMed Central
Google Scholar
Clayton NS, Grose RP. Emerging roles of fibroblast growth factor 10 in Cancer. Front Genet. 2018;9:499.
Article
CAS
PubMed
PubMed Central
Google Scholar
Veltmaat JM, Relaix F, Le LT, Kratochwil K, Sala FG, van Veelen W, et al. Gli3-mediated somitic Fgf10 expression gradients are required for the induction and patterning of mammary epithelium along the embryonic axes. Development. 2006;133(12):2325–35.
Article
CAS
PubMed
Google Scholar
Grigoriadis A, Mackay A, Reis-Filho JS, Steele D, Iseli C, Stevenson BJ, et al. Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data. Breast Cancer Res. 2006;8(5):R56.
Article
PubMed
PubMed Central
CAS
Google Scholar
Theodorou V, Boer M, Weigelt B, Jonkers J, van der Valk M, Hilkens J. Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomas. Oncogene. 2004;23(36):6047–55.
Article
CAS
PubMed
Google Scholar
Stacey SN, Manolescu A, Sulem P, Thorlacius S, Gudjonsson SA, Jonsson GF, et al. Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet. 2008;40(6):703–6.
Article
CAS
PubMed
Google Scholar
Campbell TM, Castro MAA, de Oliveira KG, Ponder BAJ, Meyer KB. ERα binding by transcription factors NFIB and YBX1 enables FGFR2 signaling to modulate estrogen responsiveness in breast Cancer. Cancer Res. 2018;78(2):410–21.
Article
CAS
PubMed
Google Scholar
Campbell TM, Castro MAA, de Santiago I, Fletcher MNC, Halim S, Prathalingam R, et al. FGFR2 risk SNPs confer breast cancer risk by augmenting oestrogen responsiveness. Carcinogenesis. 2016;37(8):741–50.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chioni AM, Grose R. FGFR1 cleavage and nuclear translocation regulates breast cancer cell behavior. J Cell Biol. 2012;197(6):801–17.
Article
CAS
PubMed
PubMed Central
Google Scholar
Clark JC, Tichelaar JW, Wert SE, Itoh N, Perl AK, Stahlman MT, et al. FGF-10 disrupts lung morphogenesis and causes pulmonary adenomas in vivo. Am J Physiol Lung Cell Mol Physiol. 2001;280(4):L705–15.
Article
CAS
PubMed
Google Scholar
Noy R, Pollard JW. Tumor-associated macrophages: from mechanisms to therapy. Immunity. 2014;41(1):49–61.
Article
CAS
PubMed
PubMed Central
Google Scholar
Hirakawa S, Kodama S, Kunstfeld R, Kajiya K, Brown LF, Detmar M. VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis. J Exp Med. 2005;201(7):1089–99.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kowanetz M, Ferrara N. Vascular endothelial growth factor signaling pathways: therapeutic perspective. Clin Cancer Res. 2006;12(17):5018–22.
Article
CAS
PubMed
Google Scholar
Mineo TC, Ambrogi V, Baldi A, Rabitti C, Bollero P, Vincenzi B, et al. Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer. J Clin Pathol. 2004;57(6):591–7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Abhinand CS, Raju R, Soumya SJ, Arya PS, Sudhakaran PR. VEGF-A/VEGFR2 signaling network in endothelial cells relevant to angiogenesis. J Cell Commun Signal. 2016;10(4):347–54.
Article
PubMed
PubMed Central
Google Scholar
Van der Auwera I, Van Laere SJ, Van den Eynden GG, Benoy I, van Dam P, Colpaert CG, et al. Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification. Clin Cancer Res. 2004;10(23):7965–71.
Article
PubMed
Google Scholar
Bièche I, Lerebours F, Tozlu S, Espie M, Marty M, Lidereau R. Molecular profiling of inflammatory breast cancer: identification of a poor-prognosis gene expression signature. Clin Cancer Res. 2004;10(20):6789–95.
Article
PubMed
Google Scholar
Liu J, Liu Y, Gong W, Kong X, Wang C, Wang S, et al. Prognostic value of insulin-like growth factor 2 mRNA-binding protein 3 and vascular endothelial growth factor-a in patients with primary non-small-cell lung cancer. Oncol Lett. 2019;18(5):4744–52.
CAS
PubMed
PubMed Central
Google Scholar
Wedam SB, Low JA, Yang SX, Chow CK, Choyke P, Danforth D, et al. Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer. J Clin Oncol. 2006;24(5):769–77.
Article
CAS
PubMed
Google Scholar
Yang SX, Steinberg SM, Nguyen D, Wu TD, Modrusan Z, Swain SM. Gene expression profile and angiogenic marker correlates with response to neoadjuvant bevacizumab followed by bevacizumab plus chemotherapy in breast cancer. Clin Cancer Res. 2008;14(18):5893–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ramjiawan RR, Griffioen AW, Duda DG. Anti-angiogenesis for cancer revisited: is there a role for combinations with immunotherapy? Angiogenesis. 2017;20(2):185–204.
Article
PubMed
PubMed Central
Google Scholar
Zhao HL, Yu JH, Huang LS, Li PZ, Lao M, Zhu B, et al. Relationship between vascular endothelial growth factor -2578C > a gene polymorphism and lung cancer risk: a meta-analysis. BMC medical genetics. 2020;21(1):17.
Article
CAS
PubMed
PubMed Central
Google Scholar
Yao W, Yan R, Ma L, Wan H, Yu Y, Cheng X, et al. Vascular endothelial growth factor gene polymorphism (−634G/C) and breast cancer risk. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 2014;35(8):7793–8.
Article
CAS
Google Scholar
Zeng Y, Huang K, Huang W. The effect analysis of CYP2D6 gene polymorphism in the toremifene and tamoxifen treatment in patient with breast cancer. Pak J Pharm Sci. 2017;30(3(Special)):1095-1098.
Naikoo NA, Afroze D, Rasool R, Shah S, Ahangar AG, Bhat IA, et al. SNP and haplotype analysis of vascular endothelial growth factor (VEGF) gene in lung Cancer patients of Kashmir. Asian Pacific journal of cancer prevention : APJCP. 2017;18(7):1799–804.
PubMed
PubMed Central
Google Scholar
Qi H, Zhang W, Wang Y, Ge M, Wang T, Zhang L, Zhong M, Shi X, Liang X, Zhan Q et al: VEGF single nucleotide polymorphisms predict improved outcome in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. J Chemother 2022:1–10.
Sullivan I, Riera P, Andrés M, Altés A, Majem M, Blanco R, et al. Prognostic effect of VEGF gene variants in metastatic non-small-cell lung cancer patients. Angiogenesis. 2019;22(3):433–40.
Article
CAS
PubMed
Google Scholar
Yang F, Qin Z, Shao C, Liu W, Ma L, Shu Y, et al. Association between VEGF gene polymorphisms and the susceptibility to lung Cancer: an updated Meta-analysis. Biomed Res Int. 2018;2018:9271215.
PubMed
PubMed Central
Google Scholar
Glenjen N, Mosevoll KA, Bruserud Ø. Serum levels of angiogenin, basic fibroblast growth factor and endostatin in patients receiving intensive chemotherapy for acute myelogenous leukemia. Int J Cancer. 2002;101(1):86–94.
Article
CAS
PubMed
Google Scholar
Akyol M, Alacacioglu A, Demir L, Kucukzeybek Y, Yildiz Y, Gumus Z, et al. The alterations of serum FGF-21 levels, metabolic and body composition in early breast cancer patients receiving adjuvant endocrine therapy. Cancer Biomark. 2017;18(4):441–9.
Article
CAS
PubMed
Google Scholar
Fujimoto J, Hori M, Ichigo S, Hirose R, Tamaya T. Antiestrogenic compounds inhibit estrogen-induced expressions of basic fibroblast growth factor and its mRNA in well-differentiated endometrial cancer cells. Gen Pharmacol. 1997;28(2):215–9.
Article
CAS
PubMed
Google Scholar
Xiaochen Z. Changes of serum vascular endothelial growth factor and basic fibroblast growth factor in breast cancer patients before and after chemotherapy. Zhejiang University; 2005.
Wen X, Shen Z, Shao Z, Shen Z. Effect of different estrogen receptor subtypes on vascular endothelial growth factor protein expression in human breast cancer samples. Zhonghua Wai Ke Za Zhi. 2002;40(3):175–6.
PubMed
Google Scholar
Wang Y, Li J, Chang S, Dong Y, Che G. Prognostic characteristics of operated breast Cancer patients with second primary lung Cancer: a retrospective study. Cancer Manag Res. 2021;13:5309–16.
Article
PubMed
PubMed Central
Google Scholar